These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Ichiyama T; Siba P; Suarkia D; Reeder J; Takasu T; Miki K; Maeba S; Furukawa S Cytokine; 2006 Jan; 33(1):17-20. PubMed ID: 16413199 [TBL] [Abstract][Full Text] [Related]
4. Intrathecal production of measles-specific IgA in subacute sclerosing panencephalitis. Visudtibhan A; Mehta PD; Kulczycki J; Coyle PK; Thormar H Acta Neurol Scand; 1997 Aug; 96(2):97-100. PubMed ID: 9272185 [TBL] [Abstract][Full Text] [Related]
5. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis. Aydin OF; Ichiyama T; Anlar B Brain Dev; 2010 Jun; 32(6):463-6. PubMed ID: 19481385 [TBL] [Abstract][Full Text] [Related]
6. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Hauser SL; Doolittle TH; Lincoln R; Brown RH; Dinarello CA Neurology; 1990 Nov; 40(11):1735-9. PubMed ID: 2234430 [TBL] [Abstract][Full Text] [Related]
7. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis. Mehta PD; Kulczycki J; Patrick BA; Sobczyk W; Wisniewski HM J Neurol Sci; 1992 May; 109(1):64-8. PubMed ID: 1381411 [TBL] [Abstract][Full Text] [Related]
14. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings. Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741 [TBL] [Abstract][Full Text] [Related]
15. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Mattson DH; Roos RP; Arnason BG Ann Neurol; 1981 Jan; 9(1):34-41. PubMed ID: 6163394 [TBL] [Abstract][Full Text] [Related]
16. Extended repertoire of specific antibodies in CSF of patients with subacute sclerosing panencephalitis compared to those with multiple sclerosis: anti-bacterial antibodies are also increased. Persson MA; Laurenzi MA; Vranjesevic D J Neuroimmunol; 1989 Apr; 22(2):135-42. PubMed ID: 2925841 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. Tsukada N; Miyagi K; Matsuda M; Yanagisawa N; Yone K J Neurol Sci; 1991 Aug; 104(2):230-4. PubMed ID: 1940977 [TBL] [Abstract][Full Text] [Related]
18. DNA and RNA antibodies in serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients. Schuller E; Delasnerie N; Lebon P J Neurol Sci; 1978 Jun; 37(1-2):31-6. PubMed ID: 308530 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis. Ichiyama T; Matsushige T; Siba P; Suarkia D; Takasu T; Miki K; Furukawa S J Infect; 2008 May; 56(5):376-80. PubMed ID: 18395263 [TBL] [Abstract][Full Text] [Related]
20. Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis. Piskin IE; Karakas-Celik S; Calik M; Abuhandan M; Kolsal E; Genc GC; Iscan A DNA Cell Biol; 2013 Jun; 32(6):336-40. PubMed ID: 23656272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]